On march 19, 2020, abbott vascular determined that a field safety corrective action is required regarding one lot of the xience sierra rx everolimus eluting coronary stent system.Devices from this lot were shipped with a 36-month labeled expiration date instead of the 12-month expiration date that is currently approved in the united states.The label indicates an expiration date of march 21, 2022, while the fda approved expiration date is march 31, 2020.This action does not affect patients having successfully undergone procedures using these devices.The customer reported the device is retained by hospital and not returning.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.H7 - if remedial action initiated updated from "none selected" to "notification".
|